test44
https://www.cytel.com/blog/optimizing-human-machine-partnership-for-up-to-date-evidence
May 4, 2022
If you are a pharmaceutical or biotech company seeking to enter the market with a new drug, you need to submit a..
Read article
test44
https://www.cytel.com/blog/time-check-developing-new-therapeutics
April 5, 2022
Hello! I’m delighted to pen my inaugural blog post here as Cytel’s Chief Medical Officer. In this series, we’ll explore..
Read article
test44
https://www.cytel.com/blog/anna-forsythe-on-aligning-clinical-strategy-with-regulatory-and-market-objectives
December 7, 2021
Sponsors bringing a successful new product to market have to overcome two hurdles: submission and reimbursement. For..
Read article
test44
https://www.cytel.com/blog/how-to-harness-technology-to-align-regulatory-and-market-access-evidence-strategies-a-new-podcast
November 17, 2021
Traditionally, the teams responsible for clinical development and regulatory submissions do not consult the market..
Read article
